DIA Biosimilars 2013

Cancer Research Technology

Cancer Research Technology Pioneer fund, BACIT, Sareum ink agreement

Friday, September 27, 2013 11:18 AM

The Cancer Research Technology Pioneer Fund (CPF), Battle Against Cancer Investment Fund (BACIT) and drug discovery company Sareum, have entered into an agreement to co-fund the further development of a class of cancer drugs called CHK1 inhibitors.

More... »

Cenduit: Now with Patient Reminders

Forma Therapeutics, CRT collaborate

Thursday, July 11, 2013 12:11 PM

Forma Therapeutics and Cancer Research Technology (CRT), the commercialization company of Cancer Research U.K., have announced a research initiative to discover tools, technologies and therapeutic drug candidates against a variety of protein homeostasis regulators called deubiquitinating enzymes (DUBs).

More... »

CRF Health – eCOA Forum

Cancer Research U.K. and Astex’s CRT initiate AT13148 trial for cancer

Friday, January 18, 2013 03:18 PM

Cancer Research Technology (CRT), the commercial arm of Astex Pharmaceuticals, a pharmaceutical company focused on novel small molecule therapeutics, along with its collaborator Cancer Research U.K., has initiated a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death.

More... »

CRT and ADC Therapeutics partner on antibody drug conjugates

Friday, July 6, 2012 03:02 PM

Cancer Research Technology (CRT), the commercial arm of Cancer Research U.K., and Switzerland-based ADC Therapeutics have signed agreements to develop cancer treatments called antibody drug conjugates (ADCs) using CRT antibodies and peptides and ADCT's “warhead” and linker chemistries.

More... »

U.K. groups unveil innovative $80 million cancer fund

Friday, March 30, 2012 09:22 AM

Cancer Research Technology (CRT), Cancer Research UK's commercial arm, and the European Investment Fund (EIF) have joined together to create an $80 million investment fund to bridge the funding gap in the U.K. between cancer drug discovery and early development.

More... »

Drug sponsors join research partnership to accelerate drug discovery

Thursday, September 29, 2011 01:21 PM

In a bid to save both time and money, some of the industry's biggest names are experimenting with new ways to pool early-stage research, effectively taking a leaf out of the "open-source" manual that gave the world Linux software, according to Reuters.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs